Form 483

Dayan K. Gandhi, M.D. Form 483, 2026-07-02

FDA issued a Form 483 to Dayan K. Gandhi, M.D. on 2026-07-02 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Dayan K. Gandhi, M.D. · Granada Hills, United States · Issued July 2, 2026

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Jul 2026
21 CFR 312.60

FD-1572, protocol compliance

Cited by Farwa Z Razvi, Andra Lepnis

2 Jul 2026
21 CFR 312.64(b)

Safety Reports - Serious Events

Cited by Farwa Z Razvi, Andra Lepnis

Inspected site

DKDayan K. Gandhi, M.D.Granada Hills, United States

Inspection team

ALAndra Lepnis

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 312.64(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere